XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2

Accrued expenses

9 Months Ended

Sep. 30, 2022

Accrued Liabilities, Current [Abstract]

Accrued expenses

Accrued expenses

Accrued expenses consisted of the following as of September 30, 2022 and December 31, 2021:

(in thousands)			September 30, 2022						December 31, 2021
Accrued manufacturing expenses			$	13,230					$	8,476
Accrued clinical expenses			10,972						7,879
Accrued research and non-clinical expenses			5,811						3,848
Accrued payroll and related expenses			9,083						7,319
Accrued professional fees			1,822						909
Accrued other			286						285
			$	41,204					$	28,716

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration